Antifibrotic effects of a polysaccharide extracted from Ganoderma lucidum, glycyrrhizin, and pentoxifylline in rats with cirrhosis induced by biliary obstruction

Biological and Pharmaceutical Bulletin

Volumn 20, Issue 4, 1997, Pages 417-420

  Park, Eun Jeon ^a   Ko, Geonil ^a   Kim, Jaebaek ^a   Sohn, Dong Hwan ^a  

^a Wonkwang University   (South Korea)

Author keywords

antifibrotic agent; bile duct ligation scission; Ganoderma lucidum; glycyrrhizin; pentoxifylline

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GANODERMA LUCIDUM EXTRACT; GLYCYRRHIZIC ACID; PENTOXIFYLLINE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT OBSTRUCTION; BILIRUBIN BLOOD LEVEL; COLLAGEN SYNTHESIS; DRUG CONFORMATION; DRUG EFFECT; DRUG ISOLATION; FEMALE; LIVER CIRRHOSIS; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; STRUCTURE ACTIVITY RELATION;

EID: 0030958298     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.20.417     Document Type: Article

References (20)

1. Anthony P. P., Ishak K. G., Nayak N. C., Poulsen H. E., Schener P. J., Sobin L. H., J. Clin. Pathol., 31, 395-414 (1978).
2. Sherlock S., "Disease of the Liver and Biliary System," 8th ed., Blackwell Scientific Publication, London, 1989, p. 410.
3. Crowley L. V., "Introduction to Human Disease," 3rd ed., Jones and Bartlett Publishers, Boston, 1992, p. 578.
4. Chojkier M., Brenner D. A., Hepatol., 8, 176-182 (1988).
5. Hogemann B., Domschke W., Gastroenterol. Jpn., 28, 570-579 (1993).
6. Kim K. Y., Han S. S., Kim J. B., Report of Institute of Pharmaceutical Res. & Dev., Wonkwang Univ., 7, 1-10 (1991).
7. Park E. J., Kim K. Y., Kim S. W., Lee S. Y., Kim J. B., Sohn D. H., Yakhak Hoeji., 38, 337-344 (1995).
8. Nobuyuki A., Takusaburo E., Nakao I., Microbiol. Immunol., 26, 535-539 (1982).
9. Svegliati Baroni G., Curto P., Recchioni A., Mancini R., Benedetti A., Jezequel A. M., Orlandi F., Hepatology, 18, 209A (1993).
10. Rockey D. C., Maher J. J., Jarnagin W. R., Gabbiani G., Friedman S. L., Hepatology, 16, 776-784 (1992).
11. Mizoguchi M. D., Katoh H., Tsutsui H., Yamamoto S., Morisawa S., Gastroenterol. Japonica, 20, 99-103 (1985).
12. Berman B., Duncan M. R., J. Invest. Dermatol., 92, 605-610 (1989).
13. Peterson T. C., Hepatology, 17, 486-493 (1993).
14. Jamall I. S., Finelli V. N., Que Hee S. S., Anal. Biochem., 112, 70-75 (1981).
15. Schuppan D., J. Hepatol., 13, s17-s25 (1991).
16. Guzelian D. S., Lindblad W. J., Diegelmann R. F., Gastroenterol., 86, 897 (1984).
17. Brenner D. A., Alcorn J. M., Sem. Liv. Dis., 10, 75-83 (1990).
18. Kershenobich H. D., Vargas F., Garcia-Tsao G., Perez-Tamayo R., Rojkind M., Hepatology, 7, 1104A (1987).
19. Boker K., Schwarting G., Kaule G., Gunzler V., Schmidt E., J. Hepatol., 13, s35-s40 (1991).
20. Ala-Kokko L., Stenback F., Ryhanen L., J. Lab. Clin. Med., 113, 177-183 (1989).